BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22416835)

  • 1. Drug dosage individualization based on a random-effects linear model.
    Diaz FJ; Cogollo MR; Spina E; Santoro V; Rendon DM; de Leon J
    J Biopharm Stat; 2012; 22(3):463-84. PubMed ID: 22416835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualizing drug dosage by using a random intercept linear model.
    Diaz FJ; Rivera TE; Josiassen RC; de Leon J
    Stat Med; 2007 Apr; 26(9):2052-73. PubMed ID: 16847902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe and effective variability-a criterion for dose individualization.
    Holford NH; Buclin T
    Ther Drug Monit; 2012 Oct; 34(5):565-8. PubMed ID: 22960736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualization of drug therapy: history, present state, and opportunities for the future.
    Lesko LJ; Schmidt S
    Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualization of drug dosage regimens.
    Platt DR
    Clin Lab Med; 1987 Jun; 7(2):289-99. PubMed ID: 3301171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Customizing dosage drugs what contribution in therapeutic drug monitoring?].
    Abdessadek M; Magoul R; Amarti A; El Ouezzani S; Khabbal Y
    Ann Biol Clin (Paris); 2014; 72(1):15-24. PubMed ID: 24492095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualization of drug dosage--past, present and future.
    Thomson AH
    Med Monatsschr Pharm; 2003 May; 26(5):150-2. PubMed ID: 12784502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Statistical Random-Effects Linear Models in Personalized Medicine.
    Diaz FJ; Yeh HW; de Leon J
    Curr Pharmacogenomics Person Med; 2012 Mar; 10(1):22-32. PubMed ID: 23467392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin.
    Schumacher GE
    Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
    Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
    Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
    Dumont C; Chenel M; Mentré F
    J Biopharm Stat; 2014; 24(3):471-92. PubMed ID: 24697342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized dosing regimens in children based on population PKPD modelling: are we ready for it?
    Knibbe CA; Danhof M
    Int J Pharm; 2011 Aug; 415(1-2):9-14. PubMed ID: 21376791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Drug Dosage - Closing the Loop.
    Tucker GT
    Pharm Res; 2017 Aug; 34(8):1539-1543. PubMed ID: 27943015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral drug delivery in personalized medicine: unmet needs and novel approaches.
    Wening K; Breitkreutz J
    Int J Pharm; 2011 Feb; 404(1-2):1-9. PubMed ID: 21070842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of drug efficacy regions based on dosage and frequency schedules.
    Li XL; Qian L; Bittner ML; Dougherty ER
    IEEE Trans Biomed Eng; 2011 Mar; 58(3):488-98. PubMed ID: 21095860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time course of drug effects.
    Al-Sallami HS; Pavan Kumar VV; Landersdorfer CB; Bulitta JB; Duffull SB
    Pharm Stat; 2009; 8(3):176-85. PubMed ID: 19626596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.